ATOSSA THERAPEUTICS, INC. Conversion of Stock, Amount Issued
ATOSSA THERAPEUTICS, INC. (ATOS) reported Conversion of Stock, Amount Issued of $48.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2020-11-13
- ATOSSA THERAPEUTICS, INC. conversion of stock, amount issued for the quarter ending 2020-09-30 was $3.00K, a 39.99% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. conversion of stock, amount issued for the quarter ending 2019-09-30 was $5.00K.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month |
|---|---|---|---|
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $48.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $45.00K 10-Q · filed 2020-08-13 | ||
| 2019-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.71M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $1.70M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |